Literature DB >> 2776870

Breath-actuated inhalers: comparison of terbutaline Turbohaler with salbutamol Rotahaler.

A Anani1, A J Higgins, G K Crompton.   

Abstract

Two breath-actuated inhalers, the Turbohaler and the Rotahaler, were compared in 24 patients with chronic asthma using an open, cross-over study design. Patients were treated with terbutaline (500 micrograms) and salbutamol (400 micrograms) four times daily, each trial period lasting three weeks. Mean morning peak expiratory flow (PEF) values were higher during Turbohaler treatment, but were similar 15 min after inhaler use. The Turbohaler was found to be easier to use than the Rotahaler.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2776870

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


  6 in total

1.  An audit of inhaler technique among asthma patients of 34 general practitioners.

Authors:  S Hilton
Journal:  Br J Gen Pract       Date:  1990-12       Impact factor: 5.386

Review 2.  The adult patient's difficulties with inhalers.

Authors:  G K Crompton
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Identical efficacy of terbutaline multidose dry powder inhaler prior to and after 4 weeks of use by asthmatic patients.

Authors:  R A Stallaert
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 4.  Budesonide. An appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in asthma.

Authors:  R Davis; D McTavish
Journal:  Pharmacoeconomics       Date:  1995-05       Impact factor: 4.981

5.  Pulmonary deposition and clinical response of 99mTc-labelled salbutamol delivered from a novel multiple dose powder inhaler.

Authors:  M Vidgren; J Arppe; P Vidgren; L Hyvärinen; P Vainio; M Silvasti; H Tukiainen
Journal:  Pharm Res       Date:  1994-09       Impact factor: 4.200

6.  Effect of an integrated primary care model on the management of middle-aged and old patients with obstructive lung diseases.

Authors:  Marianne A Meulepas; Johanna E Jacobs; Frank W J M Smeenk; Ivo Smeele; Annelies E M Lucas; Ben J A M Bottema; Richard P T M Grol
Journal:  Scand J Prim Health Care       Date:  2007-09       Impact factor: 2.581
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.